Evidence map›Paper›PMID 24923838›Full record

ArticleScientific reports2014

A method to identify and validate mitochondrial modulators using mammalian cells and the worm C. elegans.

Pénélope A Andreux, Laurent Mouchiroud, Xu Wang, Virginija Jovaisaite, Adrienne Mottis, Sabrina Bichet, Norman Moullan, Riekelt H Houtkooper, Johan Auwerx

Abstract read
In one paragraph

Article in Scientific reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. HarnessingSensors (Basel, Switzerland) · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Mitochondrial Toxicity.Toxicological sciences : an official journal of the Society of Toxicology · 2018
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Pénélope A Andreux1] Laboratory of Integrative and Systems Physiology, École Polytechnique Fédérale de Lausanne, Switzerland [2].
Laurent MouchiroudLaboratory of Integrative and Systems Physiology, École Polytechnique Fédérale de Lausanne, Switzerland.
Xu WangLaboratory of Integrative and Systems Physiology, École Polytechnique Fédérale de Lausanne, Switzerland.
Virginija JovaisaiteLaboratory of Integrative and Systems Physiology, École Polytechnique Fédérale de Lausanne, Switzerland.
Adrienne MottisLaboratory of Integrative and Systems Physiology, École Polytechnique Fédérale de Lausanne, Switzerland.
Sabrina BichetLaboratory of Integrative and Systems Physiology, École Polytechnique Fédérale de Lausanne, Switzerland.
Norman MoullanLaboratory of Integrative and Systems Physiology, École Polytechnique Fédérale de Lausanne, Switzerland.
Riekelt H Houtkooper1] Laboratory of Integrative and Systems Physiology, École Polytechnique Fédérale de Lausanne, Switzerland [2] Laboratory Genetic Metabolic Diseases, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Johan AuwerxLaboratory of Integrative and Systems Physiology, École Polytechnique Fédérale de Lausanne, Switzerland.

Funding

Skeletal Muscle Basis for Improved Exercise Endurance in RGS14 KOR01HL106511 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, STEPHEN F · 2011 to 2019
$3.8M
Translational Systems Genetics of Mitochondria, Metabolism, and AgingR01AG043930 · NIA · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI WILLIAMS, ROBERT W. · 2013 to 2017
$2.5M
European Research Council 231138NHLBI NIH HHS 1R01HL106511NHLBI NIH HHS R01 HL106511NIA NIH HHS R01 AG043930NIA NIH HHS R01AG043930
6 · The paper itself

Abstract

Mitochondria are semi-autonomous organelles regulated by a complex network of proteins that are vital for many cellular functions. Because mitochondrial modulators can impact many aspects of cellular homeostasis, their identification and validation has proven challenging. It requires the measurement of multiple parameters in parallel to understand the exact nature of the changes induced by such compounds. We developed a platform of assays scoring for mitochondrial function in two complementary models systems, mammalian cells and C. elegans. We first optimized cell culture conditions and established the mitochondrial signature of 1,200 FDA-approved drugs in liver cells. Using cell-based and C. elegans assays, we further defined the metabolic effects of two pharmacological classes that emerged from our hit list, i.e. imidazoles and statins. We found that these two drug classes affect respiration through different and cholesterol-independent mechanisms in both models. Our screening strategy enabled us to unequivocally identify compounds that have toxic or beneficial effects on mitochondrial activity. Furthermore, the cross-species approach provided novel mechanistic insight and allowed early validation of hits that act on mitochondrial function.

Indexed as

AnimalsCaenorhabditis elegansCarcinoma, HepatocellularCell LineCell Line, TumorCluster AnalysisDrug ApprovalDrug Evaluation, PreclinicalFatty Acids, MonounsaturatedFluvastatinGene ExpressionHumansHydroxymethylglutaryl-CoA Reductase InhibitorsImidazolesIndolesLovastatinFatty Acids, MonounsaturatedFluvastatinHydroxymethylglutaryl-CoA Reductase InhibitorsImidazolesIndolesLovastatinPharmaceutical PreparationsSimvastatin

Identifiers

PMID24923838
PMCPMC4055904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.